Literature DB >> 23404560

P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region.

Alexander Gröbe1, Henning Hanken, Ahmed Al-Dam, Georg Cachovan, Ralf Smeets, Antje Krohn, Till Clauditz, Tobias Grob, Ronald Simon, Guido Sauter, Lan Kluwe, Max Heiland, Marco Blessmann.   

Abstract

OBJECTIVES: The present study aims to investigate the relevance of immunohistochemical p53 expression in carcinomas of the oral cavity and of the head and neck region. Long-term clinical and histopathological follow-up findings as well as HPV status are correlated with the results of this examination.
MATERIALS AND METHODS: Sections made from two tissue arrays composed of 222 oral squamous cell carcinomas and 427 squamous cell carcinomas of the head and neck region, respectively, were examined for p53 expression and Ki-67 index by means of immunohistochemistry. Correlation of long-term clinical findings of the patients and pathological features of tumours with laboratory results were examined statistically.
RESULTS: No significant correlation was found between the p53 immunohistochemical expression in the 207 oral carcinomas and features of the tumours and patient outcomes. There was no significant association between the Ki-67 labelling index and the p53 expression. DISCUSSION: Our failure in detecting any association of the p53 immunohistochemical expression regardless of HPV status with clinical features of these tumours suggests it lacks a prognostic value for squamous cell carcinomas of the oral cavity. CLINICAL RELEVANCE: The prognostic value of p53 immunostaining in oral squamous carcinoma is not clarified yet. In the present study, there is no impact on any prognostical item nor even a correlation with cell proliferation (Ki-67) regardless of HPV status.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404560     DOI: 10.1007/s00784-013-0939-x

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  38 in total

1.  Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.

Authors:  Anak Iamaroon; Udomrat Khemaleelakul; Surawut Pongsiriwet; Jarupan Pintong
Journal:  J Oral Pathol Med       Date:  2004-01       Impact factor: 4.253

Review 2.  The p53 story: layers of complexity.

Authors:  Antony W Braithwaite; Janice A Royds; Paul Jackson
Journal:  Carcinogenesis       Date:  2005-04-07       Impact factor: 4.944

3.  Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.

Authors:  Lucinei Roberto de Oliveira; Alfredo Ribeiro-Silva; Sérgio Zucoloto
Journal:  J Oral Pathol Med       Date:  2007-04       Impact factor: 4.253

4.  Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.

Authors:  Judit A Nemes; Levente Deli; Zoltán Nemes; Ildikó J Márton
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-03-20

5.  Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.

Authors:  S Karsai; U Abel; M Roesch-Ely; A Affolter; C Hofele; S Joos; P K Plinkert; F X Bosch
Journal:  J Pathol       Date:  2007-02       Impact factor: 7.996

6.  Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.

Authors:  Juan Carlos de Vicente; Luis Manuel Junquera Gutiérrez; Agustín Herrero Zapatero; Manuel Florentino Fresno Forcelledo; Gonzalo Hernández-Vallejo; Juan Sebastián López Arranz
Journal:  Head Neck       Date:  2004-01       Impact factor: 3.147

7.  Therapeutic strategies for head and neck cancer based on p53 status.

Authors:  Ichiro Ota; Noritomo Okamoto; Katsunari Yane; Akihisa Takahashi; Takashi Masui; Hiroshi Hosoi; Takeo Ohnishi
Journal:  Exp Ther Med       Date:  2012-02-03       Impact factor: 2.447

8.  Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

Authors:  D G Brachman; D Graves; E Vokes; M Beckett; D Haraf; A Montag; E Dunphy; R Mick; D Yandell; R R Weichselbaum
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

9.  The value of flow cytometric analysis in multicentric glomus tumors of the head and neck.

Authors:  E R Sauter; L H Hollier; G H Farr
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

10.  Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.

Authors:  Marília Gerhardt de Oliveira; Luciana Maria Pereira Ramalho; Leonilson Gaião; Daniel Humberto Pozza; Ramon Andrade de Mello
Journal:  Mol Med Rep       Date:  2012-04-18       Impact factor: 2.952

View more
  4 in total

1.  CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.

Authors:  Julie C Nienstedt; Alexander Gröbe; Patrick Lebok; Franziska Büscheck; Till Clauditz; Ronald Simon; Asmus Heumann; Guido Sauter; Christoph Moebius; Adrian Münscher; Rainald Knecht; Marco Blessmann; Max Heiland; Christina Pflug
Journal:  Clin Oral Investig       Date:  2016-07-21       Impact factor: 3.573

2.  Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions.

Authors:  Alexander Gröbe; Lena Rybak; Gerhard Schön; Ralf Smeets; Silke Tribius; Philippe Schafhausen; Till S Clauditz; Henning Hanken; Max Heiland
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-27       Impact factor: 4.553

3.  Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.

Authors:  Hye-Jin Lee; Young-Hoon Kang; Jong-Sil Lee; June-Ho Byun; Uk-Kyu Kim; Si-Jung Jang; Gyu-Jin Rho; Bong-Wook Park
Journal:  BMC Oral Health       Date:  2015-12-01       Impact factor: 2.757

4.  Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts.

Authors:  Tomasz Kaczmarzyk; Konrad Kisielowski; Rafał Koszowski; Magdalena Rynkiewicz; Ewa Gawełek; Karolina Babiuch; Anna Bednarczyk; Bogna Drozdzowska
Journal:  Clin Oral Investig       Date:  2018-03-05       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.